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Introduction
Posttranslational modification of proteins is a rapid and
efficient mechanism to modulate protein activity in response to
a given stimulus. The small ubiquitin-like modifier, SUMO,
has emerged as a complex and intriguing posttranslational
modifier with a large variety of targets and a wide-range of
effects on its substrates. Four SUMO isoforms (SUMO1-4)
have been characterized in mammalian cells (Bohren et al.,
2004; Su and Li, 2002), although SUMO4 expression is
restricted to the kidney and other specific tissues suggesting a
limited biological role for SUMO4. In contrast to SUMO4,
SUMO1-3 are all widely expressed in mammalian cells (Xu
and Au, 2005), though it is likely that these three proteins have
at least partially distinct biological roles because SUMO1
shares only 50% identity with the closely related SUMO2 and
SUMO3 (Saitoh and Hinchey, 2000). Consistent with the
sequence divergence, distinct preferences for substrates (Guo
et al., 2005; Manza et al., 2004; Rosas-Acosta et al., 2005b)
and for specific de-sumoylating proteases (Melchior et al.,
2003) have been observed for each SUMO type. Despite the
above differences, all SUMOs are covalently attached to
proteins via a series of enzymatic reactions and biochemical
steps involving the same SUMO-specific enzymes (Johnson,
2004). The activating enzyme (E1), a heterodimeric protein
composed of two subunits, SAE1 and SAE2 (Azuma et al.,
2001), transfers SUMO to Ubc9, the only E2-conjugating
enzyme (Desterro et al., 1997). The Ubc9-SUMO complex can
directly interact with specific substrates, and this interaction
leads to the formation of an isopeptide bond between SUMO
and a lysine residue on its target (Okuma et al., 1999; Tatham
et al., 2003). SUMO ligases (E3 enzymes) such as RanBP2
(Pichler et al., 2002), the PIAS protein family (Kotaja et al.,
2002), and the polycomb protein Pc2 (Kagey et al., 2003) are
not required for sumoylation in vitro, but when added to a
sumoylation reaction they substantially increase the rate of this
process and appear to play an essential role in vivo. Finally,
there are specific SUMO proteases (SENP protein family) that
are involved in both SUMO processing and de-sumoylation
(Mossessova and Lima, 2000). The continuous interplay of the
enzymes described above makes SUMO modification an
active, reversible and dynamic process in mammalian cells.
SUMO modification usually exerts significant effects on its
targets: it can increase protein stability (Desterro et al., 1998),
affect protein-protein interactions (Seeler and Dejean, 2001),
alter subcellular localization (Morita et al., 2005; Wilson and
Rangasamy, 2001), and impact nuclear trafficking (Pichler and
Melchior, 2002). To date, transcription factors (TFs) represent
the largest group of SUMO substrates identified, and the most
common effect associated with TF sumoylation is modulation
of their transcriptional activity (Gill, 2003; Verger et al., 2003).
In general, sumoylation results in the negative regulation of the
activity of most TFs, including widely expressed factors such
SUMO modification regulates the activity of numerous
transcription factors that have a direct role in cell-cycle
progression, apoptosis, cellular proliferation, and
development, but its role in differentiation processes is less
clear. Keratinocyte differentiation requires the coordinated
activation of a series of transcription factors, and as several
crucial keratinocyte transcription factors are known to be
SUMO substrates, we investigated the role of sumoylation
in keratinocyte differentiation. In a human keratinocyte
cell line model (HaCaT cells), Ca2+-induced differentiation
led to the transient and coordinated transcriptional
activation of the genes encoding crucial sumoylation system
components, including SAE1, SAE2, Ubc9, SENP1, Miz-1
(PIASx), SUMO2 and SUMO3. The increased gene
expression resulted in higher levels of the respective
proteins and changes in the pattern of sumoylated
substrate proteins during the differentiation process.
Similarly to the HaCaT results, stratified human foreskin
keratinocytes showed an upregulation of Ubc9 in the
suprabasal layers. Abrogation of sumoylation by Gam1
expression severely disrupted normal HaCaT
differentiation, consistent with an important role for
sumoylation in the proper progression of this biological
process.
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as AP-1 (Bossis et al., 2005), Sp1/Sp3 (Ross et al., 2002;
Spengler and Brattain, 2006), and C/EBP (Kim et al., 2002),
though activation has been reported for some TFs, including
TCF4 (Ihara et al., 2005) and IKaros (Arco et al., 2005). Recent
studies have established multiple mechanisms for negative
regulation of TFs by sumoylation, including recruitment of
transcriptional co-repressors such as HDACs (Shiio and
Eisenman, 2003; Yang and Sharrocks, 2004), sequestration in
the cytoplasm (Morita et al., 2005; Salinas et al., 2004) or
ubiquitylation and subsequent degradation (Ghioni et al.,
2005).
Many of the TFs known to be SUMO targets, including pRB
(Ledl et al., 2005), the p53/63/73 family (Ghioni et al., 2005;
Melchior and Hengst, 2002), AP-2 (Eloranta and Hurst, 2002),
and Sp1/Sp3 (Ross et al., 2002; Spengler and Brattain, 2006)
are involved in regulating gene expression during cell-cycle
progression and/or differentiation (Herwig and Strauss, 1997;
Li and Kellems, 2003; Santini et al., 2001), suggesting that
sumoylation could coordinate complex transcriptional
programs in the cell. Several recent studies in metazoan
systems support such a role for sumoylation in aspects of
development and differentiation. Sumoylation is required for
correct vulvar development in C. elegans (Leight et al., 2005;
Poulin et al., 2005), is implicated in male germ cell maturation
(Vigodner et al., 2006) and promotes differentiation of
postsynaptic dendrites (Shalizi et al., 2006). Sumoylation is
also critical for maintaining nuclear structure and
chromosomal segregation during blastocyst development, with
the absence of Ubc9 leading to an embryonic lethal phenotype
(Nacerddine et al., 2005).
Skin is a complex and renewable organ for which little is
known about the expression and function of the sumoylation
system, although the presence of the SUMO1 protein in a
mouse keratinocyte cell line has been reported (Zhong et al.,
2000). The epidermis comprises multiple layers of
differentiated keratinocytes that are continually regenerated
from the replicative basal layer. In skin, keratinocytes
differentiate vertically because of a Ca2+ gradient established
throughout the different epithelial layers, increasing from the
basal to the outermost layer of the epithelium (Menon et al.,
1985; Vicanova et al., 1998). Ca2+ signaling drives
proliferating keratinocytes out of the cell cycle and into a
committed path of terminal differentiation, but the intermediate
signaling transduction pathways that lead to this process are
still poorly understood (Bikle et al., 2001; Lansdown, 2002; Tu
et al., 2004). A network of keratin markers biochemically
defines the keratinocyte stage within the epithelium structure
(Eichner et al., 1986; Smith, 2003; Sun et al., 1985).
Expression of keratin 5 (K5) and keratin 14 (K14)
characterizes the basal proliferative phenotype restricted to the
stem cell layer where the Ca2+ concentration is low (Schweizer
and Winter, 1983). Early in differentiation, K5 and K14 are
repressed and differentiation markers such as K1, K10 and
involucrin begin to be expressed. Finally, keratinocytes
complete terminal differentiation by producing the outer
cornified layer of the skin characterized by markers such as
filaggrin and involucrin (Candi et al., 2005; Eichner et al.,
1986; Fuchs and Green, 1980). This pattern of markers permits
discrimination between proliferating, differentiating and
terminally differentiated keratinocytes. The well-coordinated
expression of specific sets of TFs induces and represses these
keratinocyte genes as the cells migrate through the epithelium
layers, and a number of these crucial TFs are already known
to be SUMO targets in other tissues (Girdwood et al., 2004;
Verger et al., 2003), suggesting that sumoylation might play an
important role in regulating epidermal differentiation.
Cultured keratinocytes, such as HaCaT cells, provide well-
established differentiation models that can recapitulate many
aspects of stratified epithelium (Boukamp et al., 1988; Schoop
et al., 1999). HaCaTs are spontaneously immortalized and do
not express exogenous transforming genes that could interfere
with the natural process of sumoylation and differentiation.
Moreover, HaCaT cells have the capacity to revert back and
forth between the differentiated and the basal phenotype, and
therefore are widely used to model keratinocyte differentiation
in culture (Schoop et al., 1999). Here, we examine the
sumoylation system in HaCaT cells during Ca2+-induced
differentiation. We show that the sumoylation system was
transiently upregulated by Ca2+ signaling in HaCaT cells at
both the RNA and protein level, whereas abrogation of
sumoylation led to abnormal differentiation. These results
suggest cross talk between the sumoylation system and the
keratinocyte differentiation process that contributes to the
normal program of morphological and biochemical changes
during differentiation.
Results
HaCaT cells express the SUMO machinery
The SUMO system has been extensively studied, and the
enzymes required for sumoylation are widely expressed in
many tissues (Chen et al., 1998; Johnson, 2004). However, the
sumoylation system remains largely unexplored in human
keratinocytes, an important model for differentiation. To study
the functional importance of this modifier in the context of
keratinocyte differentiation, we first developed culture
conditions to maintain HaCaT cells stably in either a basal or
differentiated phenotype. HaCaT cells cultured in 0.03 mM
Ca2+ were spindle-shaped and loosely packed (Fig. 1A). In
addition, there was little or no expression of two differentiation
markers, keratin 1 (K1) and involucrin (Inv), at the RNA (Fig.
1B) or protein (Fig. 1C) level, consistent with these cells
remaining in a basal like state. By contrast, HaCaT cells
maintained in 2.8 mM Ca2+ became more cuboidal, developed
cell-cell tight junctions, and expressed both differentiation
markers, K1 and Inv, at the RNA and protein level (Fig. 1A-
C). Under both high and low [Ca2+] conditions, the cultures
could be maintained for many passages without any subsequent
changes in morphology or marker expression pattern.
Therefore, these growth conditions allow HaCaT cells to be
stably maintained in vitro in two alternative states resembling
pre- and post-differentiated skin cells.
To characterize the sumoylation system in human
keratinocytes, basal and stably differentiated HaCaT cultures
were evaluated for expression of sumoylation components at
both the RNA and protein levels. RT-PCR and quantitative RT-
PCR (Q-PCR) analyses were used to detect transcripts for all
the core SUMO components, including SUMO1, SUMO2,
SUMO3, SAE1, SAE2 and Ubc9 (Fig. 2B,C), as well as the
differentiation marker involucrin (Fig. 2A). Additionally, one
SUMO ligase (Miz-1 or PIASx) and one SUMO protease
(SENP1) were examined by RT-PCR. Consistent with the
qualitative results shown in Fig. 1B, Q-PCR detected ~14-fold
Journal of Cell Science 120 (1)
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127Sumoylation and keratinocyte differentiation
higher levels of involucrin mRNA in the high [Ca2+]-
maintained keratinocytes compared with the low [Ca2+]
culture, confirming the differentiation state of these cells (Fig.
2A). By RT-PCR, transcripts for all of the SUMO component
genes were detected in both the basal and differentiated HaCaT
cells, indicating that the relevant genes for an active
sumoylation system were actively transcribed in both cell
populations (Fig. 2B). Although the HaCaT cells were
maintained in two distinct phenotypic states, the transcript
levels for the sumoylation components tested were similar
under both culture conditions (Fig. 2C). Immunoblot analyses
confirmed the expression of Ubc9 and SAE1 proteins, and the
levels of each of these proteins were only slightly higher in the
differentiated cells compared with the undifferentiated HaCaT
cells (Fig. 2D). Next, we tested whether the sumoylation
system was active in HaCaT cells as evidenced by the presence
of sumoylated proteins. Immunoblotting of total cell extracts
using a polyclonal anti-SUMO antibody showed that
sumoylation occurred in both the basal and differentiated cell
populations (Fig. 2E). Although the differences in expression
levels of the sumoylation components were small, the
sumoylation patterns in differentiated versus basal cells were
slightly different: bands at ~40, 60 and 95 kDa were intensified
in high [Ca2+] cells compared with basal cells (Fig. 2E,
arrows). Since the basal and differentiated cell cultures were
both equally proliferative and were generated from a single
stock of HaCaT cells, we believe that these changes in
sumoylation pattern reflect differentiation-related events rather
than intrinsic differences in genetic background or growth
capacity of the two populations of cells.
SUMO and Ubc9 are expressed in stratified human
foreskin keratinocytes
To corroborate the HaCaT observations, the expression of
SUMO and Ubc9 was evaluated in primary human foreskin
keratinocytes (HFKs) that were stratified in organotypic
cultures. Immunohistochemistry analyses were performed with
an anti-SUMO polyclonal antiserum and a purified polyclonal
antibody against Ubc9, and antibody specificity was confirmed
by blocking experiments using purified SUMO1 or Ubc9 (Fig.
3). SUMO was detected in the nucleus and cytoplasm of
keratinocytes found in all layers of the epithelium (Fig. 3C).
However, as this antiserum crossreacts with SUMO2/3 (our
unpublished observations), which SUMO types were present
and whether or not there were changes in type expression in
different layers is unclear. By contrast, Ubc9 was barely
detectable in the basal layer of the epithelium where the cells
remained relatively unstained (Fig. 3A, arrowheads). Strong
anti-Ubc9 staining was detected in the intermediate
differentiated layers just above the basal layer, and Ubc9 was
present in both the nucleus and cytoplasm of the keratinocytes
in this region (Fig. 3A, black arrows). Although Ubc9 could
be detected in nuclei throughout the upper layers (Fig. 3A and
data not shown), its overall expression faded as keratinocytes
moved closer to the outer layer of the epithelium. It appears
from these results that Ubc9 expression is low in basal cells,
transiently increases with the initiation of differentiation in the
suprabasal layers, and declines as terminal differentiation
progresses. As Ubc9 is the only E2 enzyme for sumoylation,
we speculate that the pool of sumoylated protein might be
dramatically altered as well during this process. Interestingly,
Ubc9 expression is maximal in the layers just below where
keratin 1 expression commences (compare Fig. 3A with 3E).
Overall, these analyses demonstrate that sumoylation
components are present in stratified human skin epithelium and
that Ubc9 levels change during differentiation. The similar
observations in HaCaT cultures suggest that monolayer HaCaT
cells are a good representative model of the sumoylation
system in normal human keratinocytes.
Ca2+-induced differentiation in HaCaT cells upregulates
the sumoylation system
Although only minor differences in expression of the
sumoylation components were detected between the two
steady-state populations of HaCaT cells, the
immunohistochemistry results suggested that more substantial
changes in sumoylation might be taking place during the
process of differentiation. To investigate this possibility we
examined the sumoylation system in HaCaT cells undergoing
active Ca2+-induced differentiation. Addition of Ca2+ to the
basal HaCaT cultures triggered a rapid response resulting in
repression of the basal keratin markers, morphological changes
(data not shown), and mRNA expression of differentiation
markers such as K1 and Inv within 3-4 days (Fig. 4A,B). The
Inv transcript detected by Q-PCR progressively increased from
48 to 144 hours following Ca2+ induction (Fig. 4A). Likewise,
the K1 transcript, which was completely repressed in
undifferentiated (0 hours) HaCaT cells, was detected by RT-
PCR at 72 hours post Ca2+ induction, reaching a maximum
expression by 120-144 hours (Fig. 4B). No K1 expression was
detected in uninduced cells for up to 120 hours (Fig. 4B). Note,
however, that the faint expression of K1 in uninduced cells by
Fig. 1. HaCaT cell cultures exhibit phenotypic differences in
response to Ca2+ concentration. (A) Phase-contrast microscopy of
HaCaT cells maintained in low [Ca2+] medium (0.03 mM Ca2+) or in
high [Ca2+] medium (2.8 mM Ca2+). Upon Ca2+ addition to the
medium, basal HaCaT cells take 4-7 days to assume a complete
differentiated state. Inversely, upon Ca2+ depletion, differentiated
HaCaT cells take about 3 weeks to revert to a basal phenotype.
(B) RT-PCR analyses of total mRNA harvested from basal (0.03 mM
Ca2+) and differentiated HaCaT (2.8 mM Ca2+) cultures.
(C) Immunoblot analyses showing expression of keratin 1,
involucrin, and -tubulin in total cell extracts harvested from basal
(0.03 mM Ca2+) and differentiated (2.8 mM Ca2+) HaCaT cultures.
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144 hours was the result of the HaCaT cells reaching high
confluency at this late time point (Capone et al., 2000). Based
on K1 and involucrin expression, complete in vitro
differentiation of HaCaT was reached within 144 hours after
Ca2+ induction. Therefore, we chose to limit our study to a 6-
day period during which we monitored the regulation of the
sumoylation system while the HaCaT cells progressively
differentiated. RT-PCR and Q-PCR showed rapid changes in
the transcript levels for the genes encoding many of the
sumoylation components (Fig. 4C,D). Transcripts for SUMO2,
SUMO3, Ubc9 and SAE1 were upregulated twofold or more
by 24 hours post-induction, with the SUMO2 and Ubc9
transcripts increasing fivefold or more at 144 hours post-
induction (Fig. 4C). The final increase for SUMO3 and SAE1
was more modest, reaching a maximum increase of two- to
threefold. The results for SAE2 were less clear, and the
transcript levels did not consistently cross the twofold
threshold until day 6. SENP1 transcripts detected by RT-PCR
also gradually increased up to 144 hours, whereas Miz-1
(PIASx) transcripts were expressed maximally at 48 hours
post induction and then declined (Fig. 4D). We conclude from
these observations that there is a general upregulation of
transcription of the genes for the sumoylation components
accompanying the early stages of differentiation. Interestingly,
the SUMO1 gene responded differently to Ca2+ induction than
did the SUMO2 and SUMO3 genes (Fig. 4E). SUMO1
transcript levels did not increase significantly during the first
5 days post induction with Ca2+, and even at day 6 the transcript
levels were barely at the twofold threshold. Thus, SUMO1
gene expression during Ca2+-induced differentiation appears to
be regulated differently than the genes for the other SUMO
components, though the biological significance of this result is
not yet defined.
Transcriptional upregulation of sumoylation by Ca2+ is
accompanied by increases in the corresponding proteins
and overall sumoylation
Increase of specific transcripts during a biological process is
not necessarily functionally important unless it is followed by
a corresponding increase in protein expression. Immunoblot
analyses of representative sumoylation components indicated
that the Ubc9, SAE1 and SENP1 proteins levels remained
relatively constant in uninduced cultures over the 6-day
incubation period (Fig. 5B,C). By contrast, all three of these
proteins were rapidly, but transiently, upregulated more than
threefold during HaCaT cell differentiation (Fig. 5B,C).
Maximum protein expression was reached at 48-96 hours post
induction and then declined. Although the absolute increases
for SAE1, Ubc9 and SENP1 were slightly different, the overall
expression pattern was similar for all three enzymes (Fig. 5C).
Interestingly, although protein expression levels declined 96
hours post induction, transcripts were still elevated and had not
begun to decline during the time period examined (Fig. 4C).
The explanation for this discordance is not known, but may
Journal of Cell Science 120 (1)
Fig. 2. Components of the sumoylation system are expressed in basal and differentiated HaCaT cells. RNA (A-C) or protein (D,E) were
harvested from HaCaT cells maintained in either low [Ca2+] (0.03 mM) or high [Ca2+] (2.8 mM) medium. Harvesting and analysis were
performed as described in Materials and Methods. (A) Quantitative RT-PCR of involucrin mRNA levels. (B) RT-PCR analysis of the indicated
sumoylation system genes. (C) Quantitative RT-PCR analysis of the relative levels of Ubc9, SAE1, SAE2, SUMO1, SUMO2 and SUMO3
mRNAs. (D) Immunoblots for SAE1, Ubc9 and -tubulin. SAE1 and Ubc9 blots were quantified by densitometry and normalized to -tubulin.
The graph shows the relative protein levels for HaCaT cells maintained in low and high [Ca2+] medium, and the lower panels show
representative SAE1 and Ubc9 immunoblots with their corresponding -tubulin controls. (E) Anti-SUMO immunoblot of total cell extracts
from HaCaT cells maintained in either low or high [Ca2+] medium. Protein concentrations in the extracts were normalized to -tubulin, and the
samples were resolved by 10% SDS-PAGE. Arrows indicate sumoylated proteins whose levels appear higher in the high [Ca2+] culture.
Quantitative results in A, C and D are the average of at least three independent experiments.
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129Sumoylation and keratinocyte differentiation
reflect the existence of a post-transcriptional regulatory
mechanism that controls the level of protein expression for the
different components of the sumoylation system during
keratinocyte differentiation. Nonetheless, the combined results
in Figs 2, 4 and 5 indicate that Ca2+ triggers a rapid and
coordinated activation of transcription for many SUMO system
genes leading to a corresponding accumulation of the SUMO
system proteins, eventually followed by a decline to near basal
protein levels. The observation in HaCaT cells that there is a
transient upregulation of Ubc9 expression strongly correlates
with the results from the Ubc9 immunohistochemistry data in
the stratified HFKs (Fig. 3), which showed a transient increase
in Ubc9 protein levels in the suprabasal layers that declined
with further differentiation. Importantly, as in the stratified
HFKs, the peak expression of Ubc9 in differentiating HaCaT
cells occurred just before expression of the K1 protein (Fig.
5A-C).
Next, we wanted to test whether the accumulation of
sumoylation components increased the overall population of
sumoylated targets. Total cell extracts of Ca2+-induced
HaCaT cells were collected every 24 hours up to 144 hours
post induction and were analyzed by immunoblotting (Fig.
6). Overall sumoylation was clearly increased between 96 and
144 hours and discernible changes in the sumoylation of
specific substrates were observed. During the differentiation
process, several substrates (indicated by arrows) showed
increased sumoylation, whereas a major sumoylated product
at about 70 kDa decreased (arrowhead). In addition, new
sumoylated bands appeared at about 45 and 95 kDa (arrows).
No changes in substrate sumoylation were observed in
Fig. 3. Profile of SUMO and Ubc9 expression in organotypic cultures of human foreskin keratinocytes. Tissue sections were processed and
evaluated for protein expression using antibodies to Ubc9 (A,B), SUMO (B,D), or human keratin 1 (E). For samples B and D, the respective
purified proteins (25 g Ubc9 or 7 g SUMO1) were included in the primary antibody incubation step to block detection of the corresponding
antigens. (F) Negative control where the primary antibody was absent. All sections were counterstained with hematoxylin. Arrows indicate cells
expressing high levels of Ubc9. Arrowheads indicate cells in the basal layer exhibiting low levels of Ubc9 expression.
Fig. 4. Keratinocyte differentiation is
accompanied by transcription
upregulation of the sumoylation system.
HaCaT cells maintained in low [Ca2+]
medium (Time 0) were induced to
differentiate by replacing the medium
with high [Ca2+] medium. RNA was
extracted at various times post Ca2+
induction as indicated. The extracted
RNA was analyzed for expression of
differentiation marker genes (A,B) or
sumoylation system genes (C-E), and
the mRNAs were detected either by
quantitative RT-PCR (A,C,E) or RT-PCR
(B,D). For the quantitative RT-PCR, the
0 hour time samples were set to a value
of 1, and the values at other time points
are relative to the 0 hour value. For the
RT-PCR, 18S rRNA was used as the
internal standard. The quantitative
results in A,C and E were the average of
at least three independent experiments.
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parallel cultures maintained in low Ca2+ medium (data not
shown). Enhanced sumoylation during HaCaT differentiation
was even more pronounced when the samples were evaluated
by 2D gel electrophoresis (unpublished observations). These
results indicate that the increased expression of the
sumoylation components leads to increased sumoylation
activity, and that Ca2+-induced differentiation of
keratinocytes is accompanied by dynamic changes in the
pattern of sumoylated proteins.
Inhibition of the sumoylation system perturbs the HaCaT
cell differentiation process
To investigate the functional importance of sumoylation in the
process of keratinocyte differentiation, we infected basal
HaCaT cells with an adenovirus expressing Myc-tagged Gam1
(Ad-Gam1) and then exposed the cells to high [Ca2+] medium
to trigger differentiation. Gam1 is known to inhibit
sumoylation by inducing degradation of SAE1/2 and Ubc9
(Boggio et al., 2004). By 24 hours post-infection, Gam1 was
detected in HaCaT cells infected with Ad-Gam1, but not in
cells infected with Ad-GFP (Fig. 7B). In the Ad-GFP infected
cells, the Ubc9 initially present increased 3.2-fold by 48 hours
post Ca2+ induction, consistent with the response seen in the
absence of viral infection (see Fig. 5B). By contrast, cells
expressing Gam1 showed diminished Ubc9 levels by 24 hours
and no detectable Ubc9 by 48 hours when Gam1 levels had
reached maximal expression. A similar effect was seen in co-
infections with Ad-Gam1 and Ad-GFP, indicating that Ad-GFP
had no stabilizing effect on Ubc9. In contrast to these infection
studies where the transgene could be delivered effectively into
nearly 100% of the cells, alternative attempts to inhibit
sumoylation via transfection approaches were unsuccessful
owing to the poor transfection efficiency of HaCaT cells in low
[Ca2+] medium (data not shown).
When examined microscopically, HaCaT cells expressing
Gam1 exhibited a disruption of the normal morphological
changes associated with differentiation. By 72 hours after Ad-
Journal of Cell Science 120 (1)
Fig. 5. Keratinocyte differentiation is accompanied by a transient
upregulation of several sumoylation system proteins. Parallel HaCaT
cell cultures were maintained either in low [Ca2+] medium
(Uninduced) or switched from low [Ca2+] to high [Ca2+] medium
(Induced). At the indicated times post Ca2+ induction, protein
extracts were prepared from the paired cultures. The extracts were
assayed for expression of K1 (A), Ubc9 (B), SAE1 (B), and SENP1
(B) by immunoblotting with specific antibodies. The induced and
uninduced cell extracts were also evaluated for -tubulin expression,
and the immunoblots for -tubulin are duplicated in each panel of B
for comparative purposes. (C) The immunoblots in B were quantified
by densitometry, and the values for Ubc9, SAE1, and SENP1 were
normalized against -tubulin. The 0 hour time values for both the
induced and uninduced samples were set to 1, and the values for the
later time points are relative to the 0 hour time. The quantitative
results in C are the average of at least three independent experiments.
Fig. 6. The pattern of SUMO-conjugated substrates changes during
HaCaT cell differentiation. Total cell extracts were prepared at the
indicated times post Ca2+ induction and analyzed by immunoblotting
using antibodies to SUMO1 (upper panel), -tubulin (middle panel)
or keratin 1 (lower panel). Protein concentrations in the samples were
equalized based on the -tubulin levels. The positions of molecular
size markers are shown on the right. Arrows and arrowheads indicate
bands whose quantity increased or decreased, respectively, during the
time period examined.
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Gam1/Ad-GFP co-infection and Ca2+ induction, when Ubc9
was absent, the differentiating HaCaT cells showed dramatic
cellular rearrangements, including loss of tight cell-cell
junctions and typical cuboidal shape (Fig. 7A). This abnormal
morphology was not observed in cells infected with Ad-GFP
alone at any time during the differentiation process (Fig. 7A).
We also observed that GFP expression increased in the co-
infected cultures throughout the experiment whereas in cells
infected with Ad-GFP alone, the GFP expression gradually
diminished and was almost undetectable 120 hours post
induction. This observation was consistent with the known
enhancing effect of Gam1 on transcription (Chiocca et al.,
2002), and further demonstrated Gam1 activity in HaCaT cells.
Identical morphological abnormalities were also observed in
cultures infected with Ad-Gam1 alone (data not shown).
Additionally, when basal cultures were infected with Ad-Gam1
without subsequent Ca2+ induction there was no change in cell
morphology, whereas stably differentiated HaCaT cultures
were susceptible to Gam1 (supplementary material Fig. S1).
The insensitivity of the basal cultures to Gam1 confirms the
fact that inhibition of sumoylation does not directly affect
growth or morphology of the keratinocytes in the absence of
differentiation. By contrast, the susceptibility of the stably
differentiated cells to Gam1 further links differentiation state
with a sumoylation requirement.
In addition to its inhibition of sumoylation, Gam1 is also
known to inhibit HDAC activity (Chiocca et al., 2002). To
exclude the possibility that the observed morphological effects
on HaCaT cells could be due to HDAC inhibition, we
conducted the Ca2+ induction in the presence of trichostatin A
(TSA), a chemical inhibitor of HDACs (Yoshida and
Horinouchi, 1999). Basal HaCaT cells were infected with Ad-
Fig. 7. Inhibition of sumoylation
perturbs normal HaCaT cell
differentiation. (A) HaCaT cells
undergoing Ca2+-induced
differentiation exhibit abnormal
morphology when expressing Gam1
protein. Shown are phase-contrast
and fluorescence microscopy images
of HaCaT cell cultures at 24-hour
intervals. HaCaT cells were infected
with Ad-Gam1/Ad-GFP (upper
panel; MOI 150/150) or Ad-GFP
alone (middle and bottom panels;
MOI 300) and induced to
differentiate by switching to high
[Ca2+] medium. For the bottom
panel, 100 mM TSA (an HDAC
inhibitor) was added 24 hours post
infection and induction and was re-
added in fresh medium at 48-hour
intervals. (B) Immunoblot analysis
for Ubc9, Gam1, and -tubulin in
infected HaCaT cells. Cells were
infected with the Ad-Gam1 (MOI
300), Ad-Gam1/Ad-GFP (MOI
150/150), or Ad-GFP (MOI 300) and
induced to differentiate as in A. Cell
extracts were prepared at the
indicated times and immunoblotted.
(C) Immunoblot analysis for keratin
1 and -tubulin. Cells were infected
with the indicated adenovirus
constructs at an MOI of 300. Cell
extracts were prepared and analyzed
as in B.
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GFP, induced with Ca2+, and then treated with 100 mM TSA
at 24 hours after induction and infection. GFP expression was
prolonged in the TSA-treated cultures compared with the
untreated cells, consistent with TSA-mediated enhancement of
transcription through HDAC inhibition (data not shown).
However, no abnormal morphology was observed during
differentiation in TSA, indicating that HDAC inhibition does
not contribute to the Gam1 effect on differentiating
keratinocytes (Fig. 7A).
In addition to keratinocyte morphology, the effect of Gam1
expression on the K1 differentiation marker was also evaluated.
Gam1 caused a delay in and reduction of K1 expression in
Ca2+-induced cells (Fig. 7C). Although we cannot exclude the
fact that an unknown, off-target effect of Gam1 might also
contribute to both the defects in morphology and marker
expression, the simplest explanation is that these defects are
related to the dramatic inhibition of sumoylation. Altogether,
the results presented here suggest that modification with
SUMO might be a key event for the proper timing of the steps
leading to keratinocyte differentiation, and that sumoylation
may be an important regulator for this biological process.
Discussion
Recent studies on myoblast differentiation (Riquelme et al.,
2006), embryonic development (Yamaguchi et al., 2005),
genital tissue maturation (Vigodner et al., 2006) and synaptic
formation (Shalizi et al., 2006) highlight sumoylation not only
as a modifier of individual proteins but also as a global
regulator of cellular development. In the present study, we
investigated the role of sumoylation in another complex
process, keratinocyte differentiation. Using an immortalized
human keratinocyte line (HaCaT cells), we demonstrated that
there was a coordinated transcriptional upregulation of many
sumoylation system genes upon exposure to a high [Ca2+]
environment, a well-established signal for induction of
keratinocyte differentiation (Eckert et al., 1997b). In particular,
gene expression for Ubc9, the sole conjugating enzyme for the
sumoylation process, was strongly activated. This
transcriptional upregulation of Ubc9 and several other
components of the sumoylation pathway led to increased
expression of their respective proteins and to changes in the
overall pattern of sumoylated substrates. Furthermore, in the
absence of normal sumoylation, expression of a differentiation
marker, K1 protein, was delayed, and normal keratinocyte
morphogenesis was severely perturbed. In agreement with the
HaCaT studies, both Ubc9 and SUMO proteins were expressed
in organotypic cultures of normal human foreskin
keratinocytes, consistent with an active sumoylation process in
this stratified tissue. We also noted that Ubc9 immunostaining
was most prominent in the intermediate layers of the
epithelium just above the basal layer, suggesting increased
accumulation of Ubc9 in early differentiation similar to that
seen in Ca2+-induced HaCaT cells. These combined results
strongly suggest that sumoylation helps to orchestrate proper
steps of keratinocyte differentiation and is therefore a key
regulator in this biological event.
One of the salient observations of our studies was the
coordinated transcriptional activation of multiple sumoylation
genes following exposure of basal HaCaT cells to high [Ca2+]
culture conditions. Mechanistically, such coordination could be
achieved through common promoter elements responding to
Ca2+-induced TFs. High [Ca2+], both in vitro and in vivo, is
known to trigger keratinocyte differentiation through multiple
signaling pathways that activate a set of effector TFs (Fuchs,
1990; Sharpe et al., 1989), which includes NFAT, Sp1, C/EBP
and AP1 (Eckert et al., 1997a; Santini et al., 2001). Although
the promoters for the sumoylation component genes have not
been experimentally characterized, bioinformatics analysis
(www.genomatrix.de) of the putative promoter regions for the
sumoylation genes tested in this study revealed the presence of
binding sites for various combinations of the above TFs. There
were single NFAT- and AP1-binding sites and three Sp1-
binding sites on the SUMO2 promoter; five Sp1-binding sites
on the Ubc9 promoter; three C/EBP-binding sites on the SAE1
Journal of Cell Science 120 (1)
Fig. 8. Model for differentiation-dependent changes in the sumoylation system. The model proposes a negative-feedback mechanism to explain
the transient increase in sumoylation observed during HaCaT cell differentiation. Initially, a pool of TFs, including Sp1, C/EBP and AP1, which
are known to be directly stimulated by Ca2+-induced differentiation, cause upregulation of the sumoylation system. As sumoylation activity
increases, these TFs are in turn modified by SUMO conjugation, which decreases their transcriptional activity and leads to a decline in
expression of the sumoylation pathway genes. A second feature of the model is that increased sumoylation is an active contributor to the
differentiation process, through SUMO conjugation to downstream effectors of the differentiation signals. Additional details are provided in the
text.
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promoter; and one Sp1-binding site on the predicted SAE2
promoter, consistent with all of these promoters being
stimulated concurrently by Ca2+-responsive TFs.
Concordantly, SUMO1 transcription exhibited little or no
change upon Ca2+ stimulation in HaCaT cells, and analysis of
the SUMO1 putative promoter region did not reveal any
binding sites for TFs directly activated by Ca2+. Finally, the
diversity of TF binding sites on the SUMO system promoters
could also account for the quantitatively different
transcriptional responses among the SUMO components that
did respond to Ca2+ signaling. Detailed promoter studies will
be needed to determine which, if any, of these predicted TF
binding sites are directly influencing transcriptional expression
of the sumoylation genes.
The observed upregulation of the sumoylation system
appears to be a transient process associated with active
differentiation, because overall transcript and protein levels for
the sumoylation components vary only slightly between cells
stably maintained in basal versus differentiated conditions
(Fig. 2). Since the differentiating HaCaT cells remain normally
proliferative, it is likely that the sumoylation changes reflect
differentiation-dependent events and not changes related to
growth state. We propose a simple model (Fig. 8) for
downregulating the sumoylation response based on the known
repressive effect that sumoylation exerts on the activity of most
TFs (Gill, 2003). The relevant keratinocyte early differentiation
transcription factors, SP1, C/EBP and AP1, are all known to
be SUMO targets that are negatively regulated by sumoylation
(Bossis et al., 2005; Eaton and Sealy, 2003; Spengler and
Brattain, 2006; Terui et al., 2004). As sumoylation activity
increases following transcriptional upregulation of the SUMO
pathway genes, it is likely that the above TFs would become
SUMO modified and repressed, leading to a decline in
transcription of the sumoylation genes. This negative feedback
system would dampen the sumoylation response as
differentiation progresses resulting in a return to a basal level
of sumoylation activity in terminally differentiated cells.
Our transcriptional results also suggest that there are
different roles for SUMO2/3 versus SUMO1 in keratinocyte
differentiation, because we observed activation of the SUMO2
and SUMO3 promoters, but not of the SUMO1 promoter.
Additionally, we observed an increase in SENP1 protein levels
during differentiation. SENP1 cleaves the precursor forms of
all three SUMOs to produce their mature forms, but also
exhibits preferential desumoylating activity for SUMO1-
modified substrates compared with SUMO2 and SUMO3
conjugates (Xu and Au, 2005). The net result of the
transcriptional and proteolytic changes may be an overall
decrease in SUMO1 conjugates with a corresponding increase
in SUMO2 and SUMO3 modified proteins. Although the
biological significance of such a change in SUMO type
utilization is not known, growing evidence supports distinct
functions for SUMO2 and SUMO3 versus SUMO1. It is well
established that SUMO1 has only 50% identity with SUMO2
and SUMO3, whereas SUMO2 and SUMO3 are closely related
(Saitoh and Hinchey, 2000). In a recent proteomics study, we
demonstrated significant differences between the array of
targets modified by SUMO1 versus SUMO3, indicating that
these two modifications are not equivalent with regard to
substrate preference (Rosas-Acosta et al., 2005b). Other
studies have shown SUMO type-specific differences in cellular
localization (Ayaydin and Dasso, 2004), response to external
stimuli (Manza et al., 2004), and preference for SUMO ligases
(Rosas-Acosta et al., 2005a; Tatham et al., 2005) and proteases
(Gong and Yeh, 2006; Reverter and Lima, 2004), reinforcing
the concept that the individual SUMOs have both common and
unique biological activities. Intriguingly, there is evidence that
SUMO1 is more specific for nuclear substrates whereas
SUMO2 and SUMO3 targets are both nuclear and cytoplasmic
proteins (Manza et al., 2004). Cytoplasmic events, such as
formation of desmosomal junctions and specific cytoskeletal
rearrangements, mark important aspects of keratinocytes
differentiation (Hennings and Holbrook, 1983; Yin and Green,
2004). Preventing sumoylation by Gam1 expression during
HaCaT cell differentiation led to a severe disruption of cell
shape, implicating sumoylation as requisite for these
morphological changes. A direct cytoplasmic role for SUMO2
and SUMO3 modification may contribute to the dramatic
cytoskeletal changes that accompany keratinocyte
differentiation.
In conjunction with a possible direct modification of
cytoplasmic proteins, the observed increase in sumoylation
activity following Ca2+ signaling likely contributes broadly to
the keratinocyte differentiation process through effects on
nuclear TFs (Fig. 8). A recent publication by Riquelme et al
also demonstrated a sumoylation requirement during
myogenesis (Riquelme et al., 2006): when the sumoylation
system was inhibited, myoblast fusion-deficient phenotypes
were observed. Although in their system they demonstrated an
overall decrease of sumoylation during myogenesis, they
showed that further decreasing sumoylation using a siRNA to
Ubc9 dramatically affected overall myogenic differentiation
and cellular fusion. Additionally, Shalizi et al. demonstrated
the importance of sumoylation in a neuronal differentiation
system. Using granule neurons, they showed that the MEF2 TF
is activated through a Ca2+ signaling pathway in these cells,
and that sumoylation of MEF2 is necessary to promote
differentiation of dendritic claw structures (Shalizi et al.,
2006). Thus, both these studies and our own strongly support
an important role for sumoylation in cellular differentiation.
Because inactivation of proliferation-enhancing TFs, such as
p63 (Ghioni et al., 2005), has already been shown to be a
prerequisite for keratinocyte differentiation, we propose that
enhanced sumoylation facilitates this inactivation through
direct modification of these or other targets. Ongoing
proteomic studies in our laboratory are cataloging and
identifying substrates whose sumoylation status changes
during HaCaT differentiation (data not shown).
In conclusion, this study identifies sumoylation as a
potential regulator in skin biology. Ca2+ signaling stimulates
expression of the sumoylation system leading to changes in the
sumoylation state of target proteins and allowing proper
keratinocyte differentiation. Ca2+ signaling is also an important
mediator of lymphocyte activation and differentiation
(Freedman, 2006), oesteoblastic activity and bone formation
(Henriksen et al., 2006), neuronal stem cell development
(D’Ascenzo et al., 2006) and smooth muscle formation
(Wamhoff et al., 2006). Although the intermediate signals are
largely unknown for these processes, our work suggests that
sumoylation may be modulated in each of these systems
through Ca2+-responsive transcription factors. Therefore, the
interaction between Ca2+ signaling and the sumoylation system
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may also be playing a crucial role for proper development of
these and other tissues. Lastly, many skin diseases, such as
psoriasis, skin cancer (Eckert et al., 2004) or infections
resulting from microbial pathogens (Alfandari et al., 1999),
hijack the normal process of keratinocyte differentiation and
lead to abnormal skin formation. If dysregulation of
sumoylation is contributing to an aberrant differentiation
process, then modulating sumoylation might have therapeutic
benefits for the treatment of these diseases.
Materials and Methods
Cell culture
HaCaT cells (kindly provided by Gary Bokoch, The Scripps Research Institute, La
Jolla, CA) were cultured in Ca2+-free DMEM (HyClone), with Ca2+-depleted 10%
FBS (Gemini Bioproducts), 4 mM L-glutamine (HyClone), and supplemented with
calcium chloride to a final concentration of 0.03 mM (low [Ca2+] medium) or 2.8
mM final concentration (high [Ca2+] medium). FBS was Ca2+ depleted by incubation
with Chelex 100 resin (Bio-Rad Laboratories) for 1 hour at 4°C according to the
manufacturer’s protocol. The Chelex was subsequently removed using a 50 ml
Millipore 0.22 m filter unit system (Millipore Corp.). To obtain cells exhibiting a
basal keratinocyte phenotype, HaCaT cells were cultured in low [Ca2+] medium for
at least 3 weeks and were maintained in the same culture conditions thereafter. Low
[Ca2+] HaCaT cultures were never allowed to exceed 85% confluency. For stably
differentiated HaCaT cells, the cultures were maintained in high [Ca2+] medium for
at least 3 weeks before analysis. HaCaT cultures in either medium remained fully
proliferative with similar doubling times (unpublished observations). Human
embryonic kidney 293A (HEK293A) cells (Invitrogen Corp.) were maintained in
DMEM supplemented with 10% FBS (Gemini Bioproducts). For the trichostatin A
(TSA) experiment, HaCaT cells were treated with 100 mM TSA (Tocris Bioscience)
24 hours after infection with an adenoviral vector expressing GFP (Ad-GFP) and
Ca2+ induction. HaCaT cells were observed up to 144 hours post Ca2+ induction.
RT-PCR and quantitative RT-PCR
All RNAs were extracted using the RNAqueous kit (Ambion). RNA concentration
was measured using a spectrophotometer and 5 ng/l aliquots were stored at –80°C
until use. All primers were designed to overlap exon-exon junctions, therefore only
amplifying the cDNAs targets and not the genomic sequences (primer sequences
are provided in the supplementary material, Tables S1 and S2). The one-step RT-
PCR mixture contained 50 ng RNA in a final reaction volume of 25 l. The mixture
also included 2.5 l of 10 Taq DNA Polymerase buffer (Promega), 50 U MMLV
reverse transcriptase, 1 U Platinum Taq (Invitrogen), 4 mM dNTPs, 20 U RNAse
OUT (Invitrogen), 6 mM MgCl2 and 0.4 M of each primer. The one-step RT-PCR
was performed for 20 minutes at 42°C for the reverse transcription step, followed
by 90 seconds at 94°C, and 40 cycles of amplification (94°C for 30 seconds; 60°C
for 30 seconds; 72°C for 60 seconds). Amplifications were performed in a PTC-
200 Peltier Thermal Cycler machine (MJ Research). Amplified products were
analyzed on 2.5% agarose gels and visualized with an Innotech Alphaimager system
(Alpha Innotech). For the quantitative RT-PCR (Q-PCR), one step RT reactions were
performed in a single well using 50 ng of harvested RNA in a 50 l final volume.
In addition to the RT components described above, reactions for Q-PCR contained
0.2 M of LUX primers (designed with the Invitrogen custom primer software), 20
U RNAse OUT, 2 l of Super Script III enzyme solution (which includes MMLV-
RT, Platinum Taq, and dNTPs), and 1 l Rox dye, all from Invitrogen. The LUX
-actin primer set (Invitrogen) was used to detect the internal control gene. The
PCR reaction conditions for Q-PCR were the same as the RT-PCR described above.
The Q-PCR plates were read with an ABI 7500 real-time PCR instrument (Applied
Biosystems), and detection of the FAM or JOE label was recorded during the 72°C
step. Results were graphed as the fold increase of the relative quantitative RQ values
where RQ=2(–Ct). Ct was calculated as the average Ct for -actin minus the
average Ct for the gene of interest, with each sample being run in duplicate. Using
the Ct values from each time point, the Ct for each mRNA examined was
calculated as the Ct of the time 0 sample minus the Ct of time x (in hours) after
induction. The data shown are the average from at least three independent RNA
preparations collected in separate experiments.
Affinity-purified polyclonal antibodies against Ubc9
Rabbit polyclonal serum 12741 was produced in-house using affinity-purified Ubc9
as the immunogen. A four immunization regime was followed, and 2 weeks after
the final boost the rabbit was exsanguinated. To affinity purify anti-Ubc9 antibodies,
750 g affinity-purified GST-Ubc9 were diluted in a final volume of 500 l using
1 PBS, and the resulting dilution was dispensed on an 82-mm-diameter, 0.45-m-
pore-size Protran Nitrocellulose filter (Schleicher & Schuell). The membrane was
dried for 30 minutes at room temperature, then re-wetted and blocked by incubation
at room temperature for 30 minutes in 15 ml of 1 PBS supplemented with 1%
BSA. The blocked membrane was incubated for 2 hours at room temperature with
10 ml of a solution containing 2.5 ml of rabbit polyclonal serum 12741 and 7.5 ml
of 1 PBS supplemented with 10 mg/ml BSA and 0.05% Tween 20. The membrane
was subsequently washed four times each with 15 ml of 1 PBS supplemented with
0.05% Tween 20, and four additional times each with 15 ml of 1 PBS alone. The
bound antibodies were eluted by incubation with 2 ml of elution buffer (100 mM
glycine, pH 2.5, 0.02% NaN3) for 5 minutes at room temperature. The eluted
antibodies were neutralized with 200 l of 1.0 M Tris-HCl (pH 8.0), aliquoted, and
stored at –70°C. The purity of the affinity-purified antibodies was determined by
gel electrophoresis and immunoblotting, and its reactivity against Ubc9 was
determined by immunoblotting using purified Ubc9 and unfractionated mammalian
cell extracts.
Immunohistochemistry
Human foreskin keratinocytes were grown in organotypic raft cultures to form
stratified epithelium as previously described (Lambert et al., 2005). All chemicals
used for immunohistochemistry were from Biocare Medical (Concord, CA). Slides
were deparaffinized in xylene and rehydrated according to the manufacturer’s
protocols. The following antibodies and dilutions were used: anti-SUMO serum
12783 (Rosas-Acosta et al., 2005a), 1:750; affinity purified polyclonal antibodies
against Ubc9, 1:20; and polyclonal anti-human keratin 1 (anti-HK1, Covance,
Berkeley, CA), 1:5000. Specificity control blocking experiments were performed
by adding the corresponding purified proteins (25 g of Ubc9 or 7 g of SUMO1)
to the cognate antibody dilution. The SUMO and Ubc9 proteins used in the
experiments were purified as previously described (Rosas-Acosta et al., 2005a).
After immunostaining, the slides were counterstained with hematoxylin.
Immunoblots and densitometry
Total cell extracts were prepared by adding a 1:1 (v/v) mixture of RIPA buffer (50
mM Tris-HCl, pH 8, 150 mM NaCl, 5 mM EDTA, 15 mM MgCl2, 1% NP40, 0.1%
SDS, 1 mM DTT, 1:200 protease inhibitor cocktail and 10 mM N-ethylmaleimide)
and 4 sample buffer (100 mM Tris-HCl, pH 6.8, 20% glycerol, 8% SDS, 0.02%
bromophenol blue, 4% -mercaptoethanol) directly to the cells. The cells were
shaken gently for 5-10 seconds, and the resulting lysate was collected by pipetting.
Samples were heated at 95°C for 5 minutes and sonicated for 30 seconds using a
Misonix sonicator 3000 (Misonix). Samples were resolved on 10% or 12.5%
polyacrylamide gels and then transferred onto 0.45 m Immobilon-P membranes
(Millipore). The membranes were blocked for at least 15 minutes with 3% non-fat
milk in TTBS (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 0.005% Tween 20), and
incubated for 1 hour or overnight with the primary antibodies listed below at the
indicated dilution: rabbit anti -tubulin (Santa Cruz Biotechnology), 1:15,000; anti-
Myc monoclonal antibody (Santa Cruz Biotechnology), 1:500; anti-RanGAP
monoclonal antibody (Zymed/Invitrogen Corp.), 1:2500; rabbit serum 12783 against
SUMO (Rosas-Acosta et al., 2005b), 1:1000; affinity-purified polyclonal antibodies
against Ubc9, 1:500; anti-human K1 rabbit serum (Covance), 1:1000; anti-SAE1
sheep serum (Axxora), 1:2000; anti-SENP1 rabbit serum (Imgenex), 1:2000; and
anti-involucrin rabbit serum (LabVision), 1:1000. After reaction with the primary
antibodies, the membranes were incubated with Horseradish Peroxidase-conjugated
antibodies (Santa Cruz Biotechnology) at 1:10,000 for 1 hour. The membranes were
subsequently rinsed in TTBS, treated with the Western Lightning
Chemiluminescence reagent (PerkinElmer Life and Analytical Sciences), and then
visualized with X-ray film. Quantitative differences were determined by
densitometry using an Innotech Alphaimager (Alpha Innotech) and were normalized
to the -tubulin signal. Quantitative results are the average of at least three separate
experiments.
Virus production and infection
Myc-tagged Gam1 adenoviral DNA (Ad-Gam1) was kindly provided by Matt
Cotten (GPC-biotech, Munich, Germany). The Ad-Gam1 DNA was transfected into
HEK 293A cells using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s recommendation. Cells were lysed by freeze-thaw and the
supernatant was collected. The initial viral stock was subsequently amplified with
two rounds of infection on HEK 293A cells and the final freeze-thaw supernatant
collected as the high-titer stock. Adenovirus expressing GFP (Ad-GFP) was kindly
provided by G. Davis (Texas A&M Health Science Center, College Station, TX)
and amplification was performed as above. Titer was assessed by the limiting-
dilution method (Qbiogene Adenovirus Manual, version 1.4) using HEK 293A cells
plated at 1106 cells/well on six-well plates. For adenovirus experiments, HaCaT
cells maintained in low [Ca2+] medium were plated at 5106 in T75 flasks 20 hours
before infection. Each culture was infected at an MOI of 300 in 3 ml of Ca2+-free
medium supplemented with 8 g/ml polybrene (Fisher Scientific). Three hours after
infection the medium was removed, cells were trypsinized, and released cells were
resuspended in 10 ml of high [Ca2+] medium to induce differentiation. The resulting
cells suspension was split among the wells of a six-well plate at a ratio such that
the cells in each well would achieve approximately 80% confluency by the time of
collection. Cells were maintained in high [Ca2+] medium and harvested at various
times post plating by direct lysis in the wells using the 1 RIPA:4 sample buffer
mixture described above. Proteins were analyzed by immunoblotting as described
in the previous section. Cells were visualized by phase contrast and fluorescence
Journal of Cell Science 120 (1)
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microscopy at a magnification of 200 using an Olympus IX70 microscope. Images
were captured digitally using a Qcolor3 camera (Olympus). 
We thank Gary Bokoch for the providing us with the HaCaT cell
line, Matthew Cotten for providing us with the Gam1 adenoviral
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